High Levels of Gpr30 Protein in Human Testicular Carcinoma In Situ and Seminomas Correlate with Low Levels of Estrogen Receptor-Beta and Indicate a Switch in Estrogen Responsiveness

Journal of Cellular Physiology

Volumn 230, Issue 6, 2015, Pages 1290-1297

  Boscia, Francesca ^a   Passaro, Carmela ^a   Gigantino, Vincenzo ^b   Perdonà, Sisto ^b   Franco, Renato ^b   Portella, Giuseppe ^a   Chieffi, Sergio ^a   Chieffi, Paolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C FOS; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA IN SITU; ENZYME ACTIVATION; FEMALE; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MALE; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; SEMINOMA; TESTIS CARCINOGENESIS; TESTIS CARCINOMA; WESTERN BLOTTING; YOUNG ADULT; ANALOGS AND DERIVATIVES; CELL PROLIFERATION; DOWN REGULATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; TESTIS TUMOR;

ADULT; CELL PROLIFERATION; DOWN-REGULATION; ESTROGEN RECEPTOR BETA; ESTROGENS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 84923309898     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24864     Document Type: Article

References (56)

1. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M. 2007. G protein'coupled receptor 30 (GPR30) mediatesgene expression changes and growth response to 17beta'estradiol and selective GPR30 ligandG'1 in ovarian cancer cells. Cancer Res 67:1859-1866.
2. Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, Lappano R, Picard D, Mauro L, Andò S, Maggiolini M. 2008. Epidermal growth factor induces G protein coupledreceptor 30 expression in estrogen receptor'negative breast cancer cells. Endocrinol 149:3799-3808.
3. Barbagallo F, Paronetto MP, Franco R, Chieffi, P, Dolci S, Fry AM, Geremia R, Sette C. 2009. Increased expression and nuclear localizationof the centrosomal kinase Nek2 in human testicular seminomas. J Pathol 217:431-441.
4. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER. 2006. Virtual andbiomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2:207-212.
5. Boscia F, D'Avanzo C, Pannaccione A, Secondo A, Casamassa A, Formisano L, Guida N, Sokolow S, Herchuelz A, Annunziato L. 2012. Silencing or knocking out the Na(+)/Ca(2 +) exchanger-3 (NCX3) impairs oligodendrocyte differentiation. Cell Death Differ. 19:562-572.
6. Boscia F, Esposito CL, Casamassa A, de Franciscis V, Annunziato L, Cerchia L. 2013. The isolectin IB4 binds RET receptor tyrosine kinase in microglia. J Neurochem 126:428-436.
7. Botti G, Franco R, Carbone A. 2008. Sample conservation: Freezing, fixation and quality control. Pathologica 100:76-85.
8. Chevalier N, Vega A, Bouskine A, Siddeek B, Michiels JF, Chevallier D, Fénichel P. 2012. GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One 7:e34672. DOI: 10.1371/journal.pone.0034672
9. Chieffi P. 2007. Molecular targets for the treatment of testicular germ cell tumors. Mini-Rev Med Chem 7:755-759.
10. Chieffi P. 2011a. Potential new anticancer molecular targets for the treatment of human testicular seminomas. Mini-Rev Med Chem 11:1075-1081.
11. Chieffi P. 2011b. New prognostic markers and potential therapeutic targets in human testicular germ cell tumors. Curr Med Chem 18:5033-5040.
12. Chieffi P. 2014. Recent advances in molecular and cell biology of testicular germ cell tumors. Int Rev Cell Mol Biol 312:79-100.
13. Chieffi P, Chieffi S. 2013a. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumours: an overview. J Cell Physiol 228:1641-1646.
14. Chieffi P, Chieffi S. 2013b. An Up-date on the molecular biomarkers as potential therapeutic Targets in human testicular germ cell tumours. Open Androl J 5:6-9.
15. Chieffi P, Chieffi S. 2014. An Up-date on newly discovered immunohistochemical biomarkers for the diagnosis of human testicular germ cell tumors. Histol Histopathol 29:999-1006.
16. Chieffi P, Chieffi S, Franco R, Sinisi A. 2012. Recent advances in the biology of germ cell tumors: implications for the diagnosis and treatment. J Endocrinol Inv 35:1015-1020.
17. Chieffi P, Colucci D'Amato GL, Staibano S, Franco R, Tramontano D. 2000. Estradiol-induced mitogen-activated protein kinase (extracellular signal-regulated kinase 1 and 2) activity in the frog (Rana esculenta) testis. J Endocrinol 167:77-84.
18. Chieffi P, Franco R, Portella G. 2009. Molecular and cell biology of testicular tumors. Int Rev Cell Mol Biol 278:277-308.
19. Chieffi P, Troncone G, Caleo A, Libertini S, Linardopoulos S, Tramontano D, Portella G. 2004. Aurora B expression in normal testis and seminomas. J Endocrinol 181:263-270.
20. Chimento A, Sirianni R, Casaburi I, Pezzi V. 2014. GPER signaling in spermatogenesis and testicular tumors. Front Endocrinol (Lausanne) 5:30. DOI: 10.3389/fendo.2014.00030
21. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak T, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. 2009. In vivo effects of a GPR30 antagonist. Nature Chem Biol 5:421-427.
22. De Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, van de Geijn GJ, van Drunen E, Beverloo HB, Schneider DT, Sherlock JK, Baeten J, Kitazawa S, van Zoelen EJ, van Roozendaal K, Oosterhuis JW, Looijenga LH. 2008. Further characterization of the first seminoma cell line TCam-2. Genes Chrom Cancer 47:185-196.
23. Esposito F, Boscia F, Franco R, Tornincasa M, Fusco A, Kitazawa S, Looijenga LH, Chieffi P. 2011. Down-regulation of estrogen receptor-β associates with transcriptional coregulator PATZ1 delocalization in human testicular seminomas. J Pathol 224:110-120.
24. Esposito F, Boscia F, Gigantino V, Tornincasa M, Fusco A, Franco R, Chieffi P. 2012. The high mobility group A1-oestrogen receptor β nuclear interaction is impaired in human testicular seminomas. J Cell Physiol 227:3749-3755.
25. Esposito F, Libertini S, Franco R, Abagnale A, Marra L, Portella G, Chieffi P. 2009. Aurora B expression in post-puberal testicular germ cell tumours. J Cell Physiol 221:435-439.
26. Fedele M, Franco R, Salvatore G, Paronetto MP, Barbagallo F, Pero R, Chiariotti L, Sette C, Tramontano D, Chieffi G, Fusco A, Chieffi P. 2008. PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol 215:39-47.
27. Fietz D, Ratzenböck C, Hartmann K, Raabe O, Kliesch S, Weidner W, Klug J, Bergmann M. 2014. Expression pattern of estrogen receptors ö and α and G-protein-coupled estrogen receptor 1 in the human testis. Histochem Cell Biol 142:421-432.
28. Filardo EJ, Quinn JA, Bland KI, Frackelton AR, Jr. 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660.
29. Filardo EJ, Thomas P. 2005. GPR30: A seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16:362-367.
30. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E. 2006. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 12:6359-6366.
31. Fischer OM, Hart S, Gschwind A, Ullrich A. 2003. EGFR signal transactivation in cancer cells. Biochem Soc Trans 31:1203-1208.
32. Franco R, Boscia F, Gigantino V, Marra L, Esposito F, Ferrara D, Pariante P, Caraglia M, Minucci S, Chieffi P. 2011. GPR30 is over-expressed in post puberal testicular germ cell tumors. Cancer Biol Ther 11:609-613.
33. Franco R, Esposito F, Fedele M, Liguori G, Pierantoni G, Botti G, Tramontano D, Fusco A, Chieffi P. 2008. Detection of high mobility group proteins A1 and A2 represents a valid diagnostic marker in post-puberal testicular germ cell tumours. J Pathol 214:58-64.
34. Hirvonen-Santti SJ, Rannikko A, Santti H, Savolainen S, Nyberg M, Jänne OA, Palvimo JJ. 2003. Down-regulation of estrogen receptor beta and transcriptional coregulator SNURF/RNF4 in testicular germ cell cancer. Eur Urol 44:742-747.
35. Hofmann MC, Narisava S, Hess RA, Millan JL. 1992. Immortalization of germ cells and somatic testicular cells using the SV40 large T antigen. Exp Cell Res 201:417-435.
36. Langer G, Bader B, Meoli L, Isensee J, Delbeck M, Noppinger PR, Otto C. 2010. A critical review of fundamental controversies in the field of GPR30 research. Steroids 75:603-610.
37. Mizuno Y, Gotoh A, Kamidono S, Kitazawa S. 1993. Establishment and characterization of a new human testicular germ cell tumor cell line (TCam-2) Nippon Hinyokika Gakkai Zasshi. 84:1211-1218.
38. Naro C, Barbagallo F, Chieffi P, Bourgeois C, Paronetto MP, Sette C. 2014. The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival. Nucleic Acids Res 42:3218-3227.
39. Oosterhuis JW, Looijenga LH. 2005. Testicular germ-cell tumors in a broader perspective. Nat Rev Cancer 5:210-222.
40. Pentikainen V, Erkkila K, Suomalainen L, Prvinen M, Dunkel . 2000. Estradiol acts as a germ cell survival factor in the human testis in vitro. J Clin Endocrinol Metab 85:2057-2067.
41. Pero R, Lembo F, Chieffi P, Del Pozzo G, Fedele M, Fusco A, Bruni CB, Chiariotti L. 2003. Translational regulation of a novel testis-specific RNF4 transcript. Mol Reprod Dev 66:1-7.
42. Pero R, Lembo F, Di Vizio D, Boccia A, Chieffi P, Fedele M, Pierantoni M, Rossi P, Iuliano R, Santoro M, Viglietto G, Bruni CB, Fusco A, Chiariotti L. 2001. RNF4 is a growth inhibitor expressed in germ cells and lost in human testicular tumours. Am J Pathol 159:1225-1230.
43. Pettersson K, Gustafsson JA. 2001. Role of estrogen receptor beta in estrogen action. Ann Rev Physiol 63:165-192.
44. Prossnitz ER, Barton M. 2011. The G-protein-coupled estrogen receptor GPER in health and disease. Nature Rev Endocrinol 7:715-726.
45. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. 2005. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630.
46. Rijlaarsdam MA, Looijenga LH. 2014. An oncofetal and developmental perspective on testicular germ cell cancer. Seminars Cancer Biol 29C: 59-74.
47. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H. 2001. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537-2541.
48. Saunders PT, Millar MR, Macpherson S, Irvine DS, Groome NP, Evans LR, Sharpe RM, Scobie GA. 2002. ERb1 and the ERb2 splice variant (ERbcx/b2) are expressed in distinct cell populations in the adult human testis. J Clin Endocrinol Metab 87:2706-2715.
49. Sirianni R, Chimento A, Ruggiero C, De Luca A, Lappano R, Andò S, Maggiolini M, Pezzi V. 2008. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line. Endocrinol 149:5043-5051.
50. Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER. 2009. GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 114:465-471.
51. Staibano S, Franco R, Mezza E, Chieffi P, Sinisi A, Pasquali D, Errico ME, Nappi C, Tremolaterra F, Somma P, Mansueto G, De Rosa G. 2003. Loss of oestrogen receptor β, high PCNA and P53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours. Histopathol 43:254-262.
52. Vicini E, Loiarro M, Di Agostino S, Corallini S, Capolunghi F, Carsetti R, Chieffi P, Geremia R, Stefanini M, Sette C. 2006. 17-b-estradiol elicits genomic and non-genomic responses in mouse male germ cells. J Cell Physiol 206:238-245.
53. Vitale G, Dicitore A, Sciortino G, Abbruzzese A, Persani L, Santini D. 2011. Role of GPR30 in testicular germ cell tumors: A potential new anticancer target. Cancer Biol Ther 11:733-735.
54. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Andò S, Maggiolini M. 2006. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 70:1414-1423.
55. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M. 2006. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20:631-646.
56. Weyant MJ, Carothers AM, Mahmoud NN, Bradlow HL, Remotti H, Bilinski RT, Bertagnolli MM. 2001. Reciprocal expression of ERα and ERβ is associated with estrogen- mediated modulation of intestinal tumorigenesis. Cancer Res 61:2547-2551.